Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography

被引:63
作者
Sentenac, S
Fernandez, C
Thuillier, A
Lechat, P
Aymard, G
机构
[1] Hop La Pitie Salpetriere, Clin Pharmacol & Drug Monitoring Unit, Paris, France
[2] Hop La Pitie Salpetriere, Dept Pharm, Paris, France
[3] Fac Pharm Chatenay Malabry, Dept Clin Pharm, UPRES 2706, Chatenay Malabry, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 793卷 / 02期
关键词
tenofovir;
D O I
10.1016/S1570-0232(03)00333-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new high-performance liquid chromatography assay was developed for the determination of tenofovir, a nucleotide analogue, in plasma. A solid-liquid extraction procedure was coupled with a reversed-phase HPLC system. The system requires a mobile phase containing Na2HPO4 buffer, tetrabutylammonium hydrogen sulfate and acetonitrile for different elution through a C-18 column with UV detection. The method proved to be accurate, precise and linear between 10 and 4000 ng/ml. The method was applied to determine trough levels of tenofovir in 11 HIV-infected patients with virologic failure under multiple antiretroviral therapy. This method was also successfully applied to a pharmacokinetic study in an HIV infected patient with renal failure. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 5 条
[1]   Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults [J].
Barditch-Crovo, P ;
Deeks, SG ;
Collier, A ;
Safrin, S ;
Coakley, DF ;
Miller, M ;
Kearney, BP ;
Coleman, RL ;
Lamy, PD ;
Kahn, JO ;
McGowan, I ;
Lietman, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2733-2739
[2]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[3]   Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs [J].
Cundy, KC ;
Sueoka, C ;
Lynch, GR ;
Griffin, L ;
Lee, WA ;
Shaw, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :687-690
[4]   LC/MS determination of the intracellular concentration of two novel aryl phosphoramidate prodrugs of PMPA and their metabolites in dog PBMC [J].
Lynch, T ;
Eisenberg, G ;
Kernan, M .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :1415-1419
[5]  
NAESENS L, 1992, CLIN CHEM, V38, P480